Abstract:Abstract Background: Breath analysis is a promising noninvasive screening technique that offers a wide range of probable possibilities to facilitate early diagnosis of lung cancer (LC). Method: Exhaled breath samples of 352 subjects were analyzed to detect C6∼C30 VOCs through thermal desorption coupled with gas chromatography-mass spectrometry (TD-GC-MS). Data were divided into three categories Lung Cancer (LC), Benign Pulmonary Disease (BPD) and Healthy control (HC). Statistical classification models were used to analyze VOCs to distinguish between HC, BPD and LC patient's early and advanced stages. Receiver operator characteristics (ROC) curves were used to select different VOCs to evaluate the accuracy, specificity, and sensitivity of the diagnostic model. Results: The analysis resulted that 10,9,11 and 10 VOCs have a significant correlation to discriminate Histology, stage, BPD from LC and HC from LC. The diagnostic model predicted accuracy, sensitivity, and specificity of NSCLC vs. SCLC is 92%, 96% and 90% with area under curve AUC>0.913. As of ROC curve with AUC>0.819 has distinguished Stage I-II vs. stage III-IV with accuracy, sensitivity, and specificity 72%, 84%, and 80%. Whereas the ROC curve with AUC>0.795 has distinguished BPD from LC with accuracy, sensitivity, and specificity 83%, 89%, and 84%. While ROC curve with AUC>0.945, accuracy, sensitivity and specificity 92%, 96%, and 90% have distinguished HC from LC. Conclusion: This study confirms that TD GC-MS is a sensitive and dependable method to distinguish the VOCs in exhaled breath. We have witnessed significant differences in breath of BPD, HC and LC subjects. Where 10,8,11 and 10 VOCs have distinguished between early from the advance stage, NSCLC from SCLC, BPD from LC and HC from LC. These VOCs has the potential to help improve LC diagnosis and prognosis. However, with the expansion of multi centers to other regions could result in more vital findings and will help improve breath analysis and the diagnosis standard. Keywords: Breath Analysis, VOC markers, lung cancer, TD-GC-MS. Citation Format: Kanhar Ghulam Muhammad, Channa Madeeha, Fu Wei, Xu Lin Xin, Yanjie Hu, Kejing Ying, Jun Liu, Xing Chen. Volatile organic compounds (VOCs) from exhaled Breath for lung cancer Staging using TD-GC-MS [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 744.

Late Breaking Abstract - Assessing Inflammatory Response to Air Pollution via VOCs in Exhaled Breath

Abstract 744: Volatile Organic Compounds (vocs) from Exhaled Breath for Lung Cancer Staging Using TD-GC-MS

The research on early detection of lung cancer with exhaled volatile organic compounds

Volatile Organic Compounds in Exhaled Breath as Fingerprints of Lung Cancer, Asthma and COPD

Exhaled volatile organic compounds and respiratory disease: recent progress and future outlook

Haze Air Pollution Health Impacts of Breath-Borne VOCs

Exploring exhaled breath volatile organic compounds in occupational asthma: A pilot cross-sectional study.

Exhaled VOC Biomarkers from Rats Injected with PMs from Thirty-One Major Cities in China.

Emissions and uptake of volatiles by sampling components in breath analysis

Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease

Associations of diet and lifestyle factors with common volatile organic compounds in exhaled breath of average-risk individuals

A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD

Breath Analysis for Lung Cancer Early Detection-A Clinical Study

Effects of Contagious Respiratory Pathogens on Breath Biomarkers

Organic Components of Personal PM2.5 Exposure Associated with Inflammation: Evidence from an Untargeted Exposomic Approach

Analysis of Human Breath Samples of Lung Cancer Patients and Healthy Controls with Solid-Phase Microextraction (SPME) and Flow-Modulated Comprehensive Two-Dimensional Gas Chromatography (GC × GC)

Air Pollution Metabolomic Signatures and Chronic Respiratory Diseases Risk: A Longitudinal Study

Human Breath As a Source of VOCs in the Built Environment, Part II: Concentration Levels, Emission Rates and Factor Analysis

Susceptibility of Individuals with Chronic Obstructive Pulmonary Disease to Respiratory Inflammation Associated with Short-Term Exposure to Ambient Air Pollution: A Panel Study in Beijing

Possible Mediation by Methylation in Acute Inflammation Following Personal Exposure to Fine Particulate Air Pollution

Shared Risk Volatile Organic Compounds Among Chronic Respiratory Diseases: Mediation Effects of System Inflammation